Being lonely is a bigger hurdle to a good night’s sleep for college students than too much time at a computer or other electronic screen, a new study by Oregon State University suggests.
FDA approves AChEI ALPHA-1062 for Alzheimer’s disease treatment
On July 29, 2024, the U.S. FDA approved Alpha Cognition Inc.’s ALPHA-1062 (Zunveyl®), an Acetylcholinesterase (AChE) inhibitor, for treating mild-to-moderate Alzheimer’s disease.
August 5, 2024